BridgeBio Pharma, Inc.
DE ˙ MUN ˙ US10806X1028
56,19 € ↓ -1,02 (-1,78%)
2026-06-01
AKTIENPREIS
SecurityDE:2CL / BridgeBio Pharma, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership633,283 shares
Latest Disclosed Value $ 47,027,596
Millennium Management Llc ownership in 2CL / BridgeBio Pharma, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 633,283 shares of BridgeBio Pharma, Inc. (DE:2CL) valued at $39,795,504 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 36,585 shares of BridgeBio Pharma, Inc.. This represents a change in shares of 1,630.99% during the quarter. The current value of the position is $35,584,172 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (2CL) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:2CL / BridgeBio Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM 10806X102 633,283 596,698 1,630.99 47,028 1,580.74 0.0196
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 36,585 -133,852 -78.53 2,798 -68.39 0.0012
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM 10806X102 170,437 -450,021 -72.53 8,852 -66.96 0.0038
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 620,458 380,538 158.61 26,791 223.02 0.0129
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 239,920 128,849 116.01 8,294 172.20 0.0044
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 111,071 73,599 196.41 3,048 219.39 0.0015
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 37,472 -204,308 -84.50 954 -84.42 0.0005
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM 10806X102 241,780 125,178 107.35 6,124 69.88 0.0028
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM 10806X102 116,602 60,839 109.10 3,605 60.15 0.0015
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 55,763 -410,291 -88.04 2,251 -81.68 0.0010
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 466,054 466,054 12,290 0.0062
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -310,569 -100.00 0 -100.00
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 310,569 226,392 268.95 5,149 703.28 0.0030
2023-02-14 2022-12-31 13F BRIDGEBIO PHARMA COM 10806X102 84,177 -1,081,131 -92.78 641 -94.47 0.0004
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM 10806X102 1,165,308 563,441 93.62 11,583 111.95 0.0068
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM 10806X102 601,867 -315,942 -34.42 5,465 -41.34 0.0034
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 917,809 -578,264 -38.65 9,316 -62.67 0.0049
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM 10806X102 1,496,073 1,258,858 530.68 24,954 124.45 0.0127
2021-11-15 2021-09-30 13F BRIDGEBIO PHARMA COM 10806X102 237,215 96,204 68.22 11,118 29.34 0.0067
2021-08-16 2021-06-30 13F BRIDGEBIO PHARMA COM 10806X102 141,011 99,169 237.01 8,596 233.57 0.0053
2021-05-17 2021-03-31 13F BRIDGEBIO PHARMA COM 10806X102 41,842 -51,600 -55.22 2,577 -61.22 0.0018
2021-02-16 2020-12-31 13F BRIDGEBIO PHARMA COM 10806X102 93,442 93,442 6,645 0.0048
2020-11-16 2020-09-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -39,680 -100.00 0 -100.00
2020-08-14 2020-06-30 13F BRIDGEBIO PHARMA COM 10806X102 39,680 -196,520 -83.20 1,294 -81.11 0.0018
2020-05-14 2020-03-31 13F BRIDGEBIO PHARMA COM 10806X102 236,200 236,200 6,850 0.0154
2020-02-14 2019-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -37,382 -100.00 0 -100.00
2019-11-14 2019-09-30 13F BRIDGEBIO PHARMA COM 10806X102 37,382 -342,537 -90.16 802 -92.17 0.0013
2019-08-15 2019-06-30 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 379,919 379,919 10,246 0.0154
2019-08-14 2019-06-30 13F BRIDGEBIO PHARMA COM 10806X102 379,919 10,246 0.0154
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM Call 50,000 110.97 2,597 153.86 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Call 23,700 72.99 1,023 116.28 n/a n/a n/a
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Call 13,700 474 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM Call 15,700 485 n/a n/a n/a
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM Call 302,700 194.46 5,206 205.52 n/a n/a n/a
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM Call 102,800 1,704 n/a n/a n/a
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Call 100,000 66.67 1,015 1.40 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Call 60,000 1,001 n/a n/a n/a
2021-05-17 2021-03-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F BRIDGEBIO PHARMA COM Call 8,000 569 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Put 7,500 206 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM Put 82,500 135.71 2,551 80.59 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Put 35,000 1,413 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Put 20,000 334 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.